![]() |
市場調査レポート
商品コード
1738826
歯科用メンブレンおよび骨移植代替物の世界市場規模:メンブレンタイプ別、骨移植代替物タイプ別、エンドユーザー別、地域別、範囲および予測Global Dental Membrane And Bone Graft Substitutes Market Size By Type of Membrane, By Type of Bone Graft Substitute, By End-User, By Geographic Scope And Forecast |
||||||
|
歯科用メンブレンおよび骨移植代替物の世界市場規模:メンブレンタイプ別、骨移植代替物タイプ別、エンドユーザー別、地域別、範囲および予測 |
出版日: 2025年05月06日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
|
歯科用メンブレンおよび骨移植代替物の市場規模は、2024年に20億7,000万米ドルと評価され、2026年から2032年にかけてCAGR 8.46%で成長し、2032年には39億7,000万米ドルに達すると予測されています。
歯科用メンブレンおよび骨移植代替物は、骨再生と組織修復を促進するために歯科インプラント手術で使用される材料です。歯科用メンブレンは、骨移植片を覆って保護し、周囲の骨とうまく融合させるために使用されます。骨移植片は、骨密度がインプラントの挿入をサポートするのに不十分な場合に、天然骨の代わりとなったり、補ったりする材料です。これらの代用品は、合成のもの、他の動物から得たもの、ヒトの組織から加工したものなどがあります。ガイド下骨再生術や副鼻腔増大術など、失われた骨構造を回復し、新たな骨形成を促進する手術には欠かせません。
歯科用メンブレンおよび骨移植代替物市場は、材料科学の進歩や、歯の問題や美容整形手術の有病率の増加によって歯科用インプラントの需要が増加していることから、急速に拡大すると予測されています。生体活性および再吸収性のメンブレンや移植片の作成などの生体材料の技術革新により、これらの製品の有効性が向上すると期待されています。
幹細胞治療や組織工学のような再生医療アプローチとの組み合わせは、その適用範囲を広げる可能性があります。人口の高齢化と口腔の健康に対する意識の高まりは、市場の拡大を促進し、新しく改良された歯科再生ソリューションの展望を開くと予想されます。
主な市場促進要因
歯科疾患と歯の喪失の頻度の増加:市場は主に歯科疾患と歯の喪失の頻度の増加によって牽引されています。世界保健機関(WHO)によると、世界中で約35億人が口腔障害に苦しんでおり、中でも永久歯の未治療う蝕(虫歯)が最も多く、23億人に影響を与えています。
高齢人口の増加:高齢者人口の増加により、歯の問題や歯を失うリスクが高まるため、歯科用メンブレンや骨移植片の必要性が高まっています。国連経済社会局によると、2050年までに世界の6人に1人が65歳を超え(人口の16%)、2019年の11人に1人(9%)から増加します。
成長するデンタルツーリズムデンタルツーリズムは、特に貧しい国々で人気が高まっており、近代的な歯科治療に対する需要の高まりにつながっています。Patients Beyond Bordersによると、デンタルツーリズム事業の2021年の市場規模は58億3,000万米ドルで、2022年から2030年の年間成長率は12.1%と予測されています。
主な課題
規制遵守:複数の地域にまたがる規制遵守の確保は大きな問題です。歯科用メンブレンや骨移植片は、米国のFDAや欧州のEMAといった保健当局が定めた厳格な要件を遵守しなければならないです。このような要件を満たすには、かなりの試験と文書化が必要であり、それには費用と時間がかかります。国家間の規制基準の相違は、国際市場参入を複雑にし、コンプライアンス違反のリスクを高めるため、製品導入を遅らせ、市場参入を制限する可能性があります。
患者のばらつき:患者の健康状態、骨質、治癒反応の個人差はすべて、歯科インプラント治療の成功に影響を及ぼします。患者の反応にばらつきがあるため、普遍的に有効な歯科用メンブレンや骨移植の代替品を製造することは困難です。様々な患者のニーズに合わせて開発するためには、さらなる研究とカスタマイズが必要となり、製品開発が複雑になり、費用もかさみます。
限られた臨床証拠:新規の歯科用メンブレンや骨移植片の有効性は、強力な臨床証拠によって裏付けられなければならないです。臨床データが不十分であったり、決定的でなかったりすると、製品の採用や市場での受容が妨げられる可能性があります。広範囲にわたる十分な臨床試験により、安全性と有効性が実証された製品であることを確認すること。また、強力な臨床データの欠如は、歯科医療関係者の不信を招き、製品の信頼性を損なう可能性があります。
主要動向:
生分解性材料:生分解性歯科用メンブレンや骨移植代替材料の開発への関心が高まっています。これらの材料は、時間の経過とともに自然に分解され、体内に吸収されることを目的としており、外科的除去の必要性をなくし、潜在的な影響を抑えることができます。生分解性のソリューションは、長期的な副作用のリスクを下げると同時に、患者の快適性を向上させる。材料科学の開発により、より効果的で安全な生分解性ソリューションの開発が可能になり、患者の治療成績の向上と歯科処置の迅速化を重視する業界を支えています。
患者中心の治療への注目の高まり:歯科治療において患者中心のサービスが重視されるようになり、それが歯科用メンブレンや代替骨移植片の開発の原動力となっています。この動向は、治療成果を向上させるだけでなく、患者の総合的な体験を向上させる製品を開発する必要性を浮き彫りにしています。快適さ、使いやすさ、療養時間の短縮は、製品開発においてますます重要になっています。こうした患者のニーズに応えることで、企業はより効果的で患者に優しいソリューションを開発することを望んでいます。
Dental Membrane And Bone Graft Substitutes Market size was valued at USD 2.07 Billion in 2024 and is projected to reach USD 3.97 Billion by 2032, growing at a CAGR of 8.46% from 2026 to 2032.
Dental membranes and bone graft substitutes are materials used in dental implant operations to promote bone regeneration and tissue repair. Dental membranes are utilized to cover and protect bone grafts, ensuring that they integrate well into the surrounding bone. Bone graft substitutes are materials that replace or supplement natural bone in locations where bone density is insufficient to support implant insertion. These alternatives may be synthetic, obtained from other animals, or processed from human tissue. They are essential in operations like guided bone regeneration and sinus augmentation, which help restore lost bone structure and promote new bone formation.
The dental membrane and bone graft replacements market is predicted to expand rapidly because of advances in materials science and increased demand for dental implants, which is being driven by the increasing prevalence of dental problems and cosmetic operations. biomaterial innovations, such as the creation of bioactive and resorbable membranes and grafts, are expected to improve the efficacy of these products.
The combination of regenerative medicine approaches, such as stem cell therapy and tissue engineering, could broaden their applicability. The aging population and growing awareness of oral health are expected to fuel market expansion, opening up prospects for new and improved dental regeneration solutions.
The key market dynamics that are shaping the global dental membrane and bone graft substitutes market include:
Key Market Drivers:
Increasing Prevalence of Dental Diseases and Tooth Loss: The market is primarily driven by the rising frequency of dental diseases and tooth loss. According to the World Health Organization (WHO), almost 3.5 billion people worldwide suffer from oral disorders, with untreated dental caries (tooth decay) in permanent teeth being the most prevalent, impacting 2.3 billion people.
Rising Geriatric Population: The growing older population increases the need for dental membranes and bone graft substitutes due to the increased risk of dental problems and tooth loss. According to the United Nations Department of Economic and Social Affairs, by 2050, one in every six individuals worldwide will be beyond the age of 65 (16% of the population), up from one in every eleven in 2019 (9%).
Growing Dental Tourism: Dental tourism is growing in popularity, especially in poorer countries, leading to increased demand for modern dental procedures. According to Patients Beyond Borders, the dental tourism business is predicted to be valued at USD 5.83 Billion in 2021, with an annual growth rate of 12.1% between 2022 and 2030.
Key Challenges:
Regulatory Compliance: Ensuring regulatory compliance across several regions presents a substantial problem. Dental membranes and bone graft substitutes must adhere to strict requirements established by health authorities such as the FDA in the United States and the EMA in Europe. Navigating these requirements necessitates considerable testing and documentation, which may be expensive and time-consuming. Discrepancies in regulatory standards between nations can complicate international market entry and raise the risk of non-compliance, thereby delaying product introductions and limiting market access.
Patient Variability: Individual variances in patients' overall health, bone quality, and healing responses can all have an impact on the success of dental implant treatments. Variability in patient responses makes it difficult to produce universally effective dental membranes and bone graft alternatives. Tailoring items to meet various patient needs necessitates additional research and customization, which complicates product development and raises expenses.
Limited Clinical Evidence: The effectiveness of novel dental membranes and bone graft substitutes must be backed up by strong clinical evidence. Insufficient or inconclusive clinical data can impede product adoption and market acceptance. Ensure that goods have a demonstrated track record of safety and efficacy through extensive and well-documented clinical trials. The lack of strong clinical data can also cause distrust among dental professionals and undermine product credibility.
Key Trends:
Biodegradable Materials: There is a rising interest in developing biodegradable dental membranes and bone transplant alternatives. These materials are intended to spontaneously degrade and be absorbed by the body over time, eliminating the need for surgical removal and limiting potential consequences. Biodegradable solutions increase patient comfort while lowering the risk of long-term side effects. Advances in materials science are enabling the development of more effective and safe biodegradable solutions, which supports the industry's emphasis on improving patient outcomes and expediting dental procedures.
Increasing Focus on Patient-Centric Care: There is a growing emphasis on patient-centered service in dentistry, which is driving the development of dental membranes and bone graft alternatives. This trend highlights the need to create products that not only improve therapeutic outcomes but also the total patient experience. Comfort, simplicity of use, and shortened recuperation time are increasingly important aspects of product development. By addressing these patient needs, businesses hope to develop more effective and patient-friendly solutions.
Here is a more detailed regional analysis of the global dental membrane and bone graft substitutes market:
North America:
North America dominates the dental membrane and bone graft substitutes market, owing to its advanced healthcare infrastructure and increased awareness of oral health. The region's high prevalence of dental disorders, with over 26% of adults in the United States suffering from untreated tooth decay and around 46% exhibiting indicators of gum disease, highlights the need for improved dental therapies. The growing older population, which is expected to nearly double from 52 million in 2018 to 95 million by 2060, is especially vulnerable to oral problems, increasing demand for dental membranes and bone graft operations. The growing use of dental implants, with 3 million Americans already having implants and 500,000 new cases each year, strongly correlates with the need for these dental materials, which are required for successful implant surgeries.
Significant investments in dental R&D also drive market expansion. For instance, the National Institute of Dental and Craniofacial Research (NIDCR) obtained a budget of USD 501.23 Million for fiscal year 2022, a large increase over previous years. This investment is expected to drive advances in dental materials and methods, such as dental membranes and bone transplant alternatives. These factors-high prevalence of dental disorders, an aging population, increasing dental implant operations, and significant R&D investment-are projected to keep North America's dominant position in the global dental membrane and bone graft substitutes market.
Asia Pacific:
The Asia Pacific region is emerging as the fastest-growing market for dental membrane and bone graft alternatives, owing to increased urbanization, rising disposable incomes, and heightened awareness of oral health and aesthetic dentistry. The WHO has highlighted the high prevalence of dental illnesses, which has a huge impact on this region, with countries such as India having dental caries prevalence in adults of up to 82.4%. The prevalence of oral diseases is driving demand for improved dental treatments. Furthermore, the growing dental tourism business in Thailand, India, and Malaysia is driving up demand for high-quality dental operations, such as dental membranes and bone transplant alternatives.
The region's rising senior population, which is expected to more than double from 535 million in 2015 to 1.3 billion by 2050, is especially vulnerable to periodontal diseases and tooth loss, necessitating the use of innovative dental solutions. Increased government investments in dental health, such as India's National Oral Health Programme, are improving oral health infrastructure and raising awareness, further encouraging the use of modern treatments. These combined factors are likely to accelerate the Asia Pacific dental membrane and bone graft substitutes market, potentially making it the world's fastest-growing region.
The Global Dental Membrane And Bone Graft Substitutes Market is Segmented on the basis of Type of Membrane, Type of Bone Graft Substitute, End-User, And Geography.
Based on Type of Membrane, the market is fragmented into Resorbable Membranes and Non-resorbable Membranes. Resorbable membranes now dominate the dental membrane and bone graft substitutes market due to their ability to eliminate the requirement for a second surgical treatment to remove the membrane. These membranes are often comprised of biocompatible materials that deteriorate slowly over time, making the treatment procedure easier for patients. Non-resorbable membranes are rapidly expanding because to their higher mechanical strength and capacity to maintain a stable barrier over an extended length of time, facilitating optimal bone regeneration. While they require a second surgery to remove, advances in material science and surgical procedures are reducing this disadvantage, adding to their growing popularity.
Based on Type of Bone Graft Substitute, the market is segmented into Allografts, Xenografts, Synthetic Grafts, and Autografts. Autografts now lead the dental membrane and bone graft substitutes market because of their better osteoconductive and osteoinductive qualities, which promote optimal bone regeneration. However, the intrusive aspect of collecting bone from a patient's own body frequently causes donor site morbidity, limiting its broad use. Synthetic grafts are emerging as the most rapidly developing segment. These grafts provide various benefits, including uniform quality, a lower risk of disease transmission, and convenience of use. Ongoing breakthroughs in material science are resulting in the creation of synthetic grafts with higher biocompatibility and osteoconductive qualities, which is driving market expansion.
Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Dental Clinics. Dental clinics is dominating the dental membrane and bone graft substitutes market owing to their extensive availability, emphasis on oral healthcare, and established patient relationships. Ambulatory surgery clinics are rapidly expanding because they provide specialized equipment and experience for difficult dental treatments including bone grafting and membrane insertion. The growing need for minimally invasive and efficient treatments is driving patients to ambulatory surgery facilities, which is contributing to their market growth.
The "Global Dental Membrane And Bone Graft Substitutes Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Geistlich Pharma AG, Straumann Group (Switzerland) Ltd, Medtronic, Danaher Corporation, Zimmer Biomet Holdings, Inc., Illeris AG, Botiss Biomaterials GmbH, Osteogenics Biomedical, Inc., BioHorizons Corp, and C.R. Bard, Inc.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.